相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial
Nadeem Riaz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
HPV, protein p16 and squamous cell carcinoma of the oral cavity
Jiri Blahak et al.
BIOMEDICAL PAPERS-OLOMOUC (2020)
Association between MGMT status and response to alkylating agents in patients with neuroendocrine neoplasms: a systematic review and meta-analysis
Zhirong Qi et al.
BIOSCIENCE REPORTS (2020)
Inhibition of MGMT-mediated autophagy suppression decreases cisplatin chemosensitivity in gastric cancer
Yuanyuan Lei et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
CDK4/6 inhibitors in P16/HPV16-negative squamous cell carcinoma of the head and neck
Camelia Billard-Sandu et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2020)
Associations among smoking, MGMT hypermethylation, TP53-mutations, and relapse in head and neck squamous cell carcinoma
Shinichi Matsuda et al.
PLOS ONE (2020)
MGMT expression affects the gemcitabine resistance of pancreatic cancer cells
Yu Shi et al.
LIFE SCIENCES (2020)
Hypermethylation status of DAPK, MGMT and RUNX3 in HPV negative oral and oropharyngeal squamous cell carcinoma
Raquel Silva dos Reis et al.
GENETICS AND MOLECULAR BIOLOGY (2020)
Temozolomide Sensitizes MGMT-Deficient Tumor Cells to ATR Inhibitors
Christopher B. Jackson et al.
CANCER RESEARCH (2019)
Human papillomavirus E7 oncoprotein targets RNF168 to hijack the host DNA damage response
Justine Sitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
NRG-HN002: A Randomized Phase II Trial for Patients With p16-Positive, Non-Smoking-Associated, Locoregionally Advanced Oropharyngeal Cancer
S. S. Yom et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Human papillomavirus and the landscape of secondary genetic alterations in oral cancers
Maura L. Gillison et al.
GENOME RESEARCH (2019)
Impact of HPV infection on gene expression and methylation in oral cancer patients
Alicja Prawdzic Senkowska et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2019)
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
Hisham Mehanna et al.
LANCET (2019)
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
Maura L. Gillison et al.
LANCET (2019)
The role of human papillomavirus in p16-positive oral cancers
Simone Belobrov et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2018)
The role of MGMT polymorphisms rs12917 and rs11016879 in head and neck cancer risk and prognosis
Pawel Kiczmer et al.
ACTA BIOCHIMICA POLONICA (2018)
Aberrant DNA methylation of the p16, APC, MGMT, TIMP3 and CDH1 gene promoters in tumours and the surgical margins of patients with oral cavity cancer
Joanna Katarzyna Strzelczyk et al.
JOURNAL OF CANCER (2018)
An update: emerging drugs to treat squamous cell carcinomas of the head and neck
Yoon Se Lee et al.
EXPERT OPINION ON EMERGING DRUGS (2018)
The molecular landscape of head and neck cancer
C. Rene Leemans et al.
NATURE REVIEWS CANCER (2018)
Differences in survival outcome between oropharyngeal and oral cavity squamous cell carcinoma in relation to HPV status
Kenneth Lai et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2017)
Comparative molecular profiling of HPV-induced squamous cell carcinomas
Robert F. Koncar et al.
CANCER MEDICINE (2017)
Prognostic Impact of AJCC/UICC 8th Edition New Staging Rules in Oropharyngeal Squamous Cell Carcinoma
Nora Wuerdemann et al.
FRONTIERS IN ONCOLOGY (2017)
Promoter methylation of MGMT in oral carcinoma: A population-based study and meta-analysis
Chinchu Jayaprakash et al.
ARCHIVES OF ORAL BIOLOGY (2017)
Biological Features of Human Papillomavirus-related Head and Neck Cancers Contributing to Improved Response
C. Cleary et al.
CLINICAL ONCOLOGY (2016)
EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer
Tim N. Beck et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer
Kiyoshi Misawa et al.
ONCOTARGET (2016)
Aberrant Methylation of MGMT Promoter in HNSCC: A Meta-Analysis
Fucheng Cai et al.
PLOS ONE (2016)
Identification of methylation markers for the prediction of nodal metastasis in oral and oropharyngeal squamous cell carcinoma
L. J. Melchers et al.
EPIGENETICS (2015)
O6-methylguanine DNA methyltransferase repairs platinum-DNA adducts following cisplatin treatment and predicts prognoses of nasopharyngeal carcinoma
Shang Hung Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Comprehensive genomic characterization of head and neck squamous cell carcinomas
Michael S. Lawrence et al.
NATURE (2015)
Human papillomavirus type 16 E7 oncoprotein causes a delay in repair of DNA damage
Jung Wook Park et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Residual nodal disease in patients with advanced-stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissection: Association with locoregional recurrence, distant metastasis, and decreased survival
Vlad C. Sandulache et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2013)
Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer
Arlene A. Forastiere et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity
Thorsten Rieckmann et al.
RADIOTHERAPY AND ONCOLOGY (2013)
The Role of Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
Tobenna Nwizu et al.
SEMINARS IN RADIATION ONCOLOGY (2012)
Human Papillomavirus as a Marker of the Natural History and Response to Therapy of Head and Neck Squamous Cell Carcinoma
Kie Kian Ang et al.
SEMINARS IN RADIATION ONCOLOGY (2012)
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1
Nishant Agrawal et al.
SCIENCE (2011)
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
K. Kian Ang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Human papillomavirus oncoproteins: pathways to transformation
Cary A. Moody et al.
NATURE REVIEWS CANCER (2010)
Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation
Emanuela Taioli et al.
BMC CANCER (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
Jean-Pierre Pignon et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Hypermethylation, risk factors, clinical characteristics, and survival in 235 patients with laryngeal and Hypopharyngeal cancers
Rajesh P. Dikshit et al.
CANCER (2007)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
MGMT: Its role in cancer aetiology and cancer therapeutics
SL Gerson
NATURE REVIEWS CANCER (2004)
Differential methylation status of tumor-associated genes in head and neck squamous carcinoma: Incidence and potential implications
SI Maruya et al.
CLINICAL CANCER RESEARCH (2004)
Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma
M Viswanathan et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
M Esteller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)